Your browser is no longer supported. Please, upgrade your browser.
Settings
PFE Pfizer Inc. daily Stock Chart
PFE [NYSE]
Pfizer Inc.
IndexDJIA S&P500 P/E19.52 EPS (ttm)1.83 Insider Own0.10% Shs Outstand5.96B Perf Week0.39%
Market Cap212.42B Forward P/E11.62 EPS next Y3.07 Insider Trans-7.55% Shs Float5.95B Perf Month-2.44%
Income11.05B PEG2.84 EPS next Q0.74 Inst Own73.20% Short Float1.10% Perf Quarter-1.71%
Sales52.67B P/S4.03 EPS this Y49.80% Inst Trans-1.18% Short Ratio2.95 Perf Half Y0.79%
Book/sh11.78 P/B3.03 EPS next Y4.07% ROA12.80% Target Price39.95 Perf Year10.61%
Cash/sh1.92 P/C18.60 EPS next 5Y6.88% ROE33.40% 52W Range31.67 - 39.43 Perf YTD-1.60%
Dividend1.36 P/FCF29.38 EPS past 5Y7.90% ROI9.90% 52W High-9.61% Beta0.88
Dividend %3.82% Quick Ratio1.00 Sales past 5Y-0.80% Gross Margin79.20% 52W Low12.54% ATR0.48
Employees90200 Current Ratio1.30 Sales Q/Q1.00% Oper. Margin24.80% RSI (14)47.79 Volatility0.96% 1.38%
OptionableYes Debt/Eq0.58 EPS Q/Q14.80% Profit Margin41.30% Rel Volume0.65 Prev Close35.71
ShortableYes LT Debt/Eq0.45 EarningsMay 01 BMO Payout35.60% Avg Volume22.18M Price35.64
Recom2.60 SMA20-0.46% SMA50-0.77% SMA200-0.01% Volume14,441,050 Change-0.20%
Apr-05-18Downgrade Barclays Overweight → Equal Weight $41 → $38
Jan-29-18Reiterated SunTrust Hold $33 → $40
Sep-20-17Upgrade Morgan Stanley Equal-Weight → Overweight
Jul-20-17Downgrade Credit Suisse Outperform → Neutral
May-16-17Downgrade Citigroup Neutral → Sell
Dec-02-16Initiated Guggenheim Neutral
Nov-02-16Downgrade Argus Buy → Hold
Oct-13-16Downgrade Jefferies Buy → Hold
Jun-20-16Reiterated Jefferies Buy $42 → $40
May-12-16Initiated Berenberg Hold $38
May-04-16Reiterated UBS Buy $36 → $38
Apr-18-16Resumed Goldman Neutral $35
Apr-07-16Resumed Morgan Stanley Equal-Weight $35
Apr-07-16Resumed JP Morgan Overweight $38
Nov-25-15Upgrade Sun Trust Rbsn Humphrey Reduce → Neutral
Nov-03-15Reiterated Argus Buy $41 → $46
Oct-28-15Reiterated Deutsche Bank Buy $41 → $43
Oct-02-15Upgrade Morgan Stanley Equal-Weight → Overweight $35 → $38
Jul-29-15Reiterated Argus Buy $39 → $41
Jun-17-15Initiated Piper Jaffray Overweight
May-18-18 03:21PM  Pfizer's Epilepsy Drug Lyrica Succeeds in Pediatric Study Zacks
02:35PM  Pharma Stock Roundup: Zoetis to Buy Abaxis, NVS Gets FDA Nod for Migraine Drug Zacks
01:35AM  [$$] AstraZeneca chief Pascal Soriot suffers pay revolt Financial Times
May-17-18 04:51PM  Invacare Corporation Appoints Petra Danielsohn-Weil, PhD, to Board of Directors Business Wire
11:27AM  Investors Need to Adopt a Different Mindset for Big Pharma and Biotech Stocks InvestorPlace
10:38AM  Sangamo Therapeutics Stock History Motley Fool
10:03AM  Roche Tecentriq Combo Achieves Longer Overall Survival Rate Zacks
09:35AM  Exelixis' Cabometyx Gets EU Nod for First-Line Kidney Cancer Zacks
08:00AM  LYRICA® (pregabalin) Oral Solution CV Phase 3 Trial in Pediatric Epilepsy Meets Primary Endpoint Business Wire
06:32AM  Is Alnylam Pharmaceuticals, Inc. (ALNY) a Buy? Motley Fool
May-16-18 07:30PM  5 Companies To Watch As Marijuana Legalization Approaches Oilprice.com
05:00PM  Pfizer Oncology to Showcase Clinical Advances from its Growing Portfolio and Research Pipeline at ASCO Business Wire
10:02AM  Pfizer Gets FDA Nod for Amgen, J&J's Anemia Drug Biosimilar Zacks
May-15-18 02:38PM  Pfizers Biosimilar RETACRIT® (epoetin alfa-epbx) Approved by U.S. FDA Business Wire
02:07PM  Pfizer's biosimilar of Amgen, J&J's anemia treatments gets FDA nod Reuters
11:54AM  FDA approves Pfizer's biosimilar of Amgen's Epogen Reuters
10:32AM  Merck KGaA (MKGAF) Q1 Earnings and Revenues Decline Y/Y Zacks
08:00AM  Free Stock Performance Review on Pfizer and Three More Drug Makers Stocks ACCESSWIRE
May-14-18 07:30PM  The Likely 5 Winners Of Canadas Cannabis Boom Oilprice.com
02:50PM  MARKETS: Alibaba, Baidu jump on Trump tweet; Disney, Walmart, UnitedHealth lead Dow higher; Retail earnings on tap Yahoo Finance Video
01:43PM  Why Trumps drug-price pitch makes no sense MarketWatch
01:25PM  The Trump Plan To Reduce Prescription Drug Prices Will Have A Major Impact Forbes
May-13-18 06:31AM  Better Buy: Pfizer Inc. (PFE) vs. Merck (MRK) Motley Fool
May-12-18 06:21AM  Trump's prescription to reduce drug prices takes small steps Associated Press
May-11-18 10:41PM  Few teeth in Trump's prescription to reduce drug prices Associated Press
05:02PM  Trump lets drug companies off the hook Yahoo Finance Video
10:17AM  US stock indexes edge higher in early trading; oil down Associated Press
10:13AM  Trump to announce ways to lower prescription drug costs Yahoo Finance Video
09:25AM  Merck vs. Pfizer: Which Stock Looks Better Post Q1 Earnings? Zacks
08:16AM  3 Healthcare Stocks Growing Over 100% Motley Fool
May-10-18 09:10AM  Unlocking The Value In Animal Medicine Forbes
01:15AM  [$$] EpiPen Emergency Allergy Shot in Short Supply, FDA Says The Wall Street Journal
May-09-18 04:47PM  Mylan Flies On Confidence In 2018 Outlook Despite EpiPen Shortage Investor's Business Daily
04:33PM  Epipen shortage should be short term: Mylan CNBC Videos
04:27PM  Johnson & Johnson Stock Looks Attractive on the Big Dip InvestorPlace
11:55AM  [$$] EpiPen Emergency Allergy Shot in Short Supply, FDA Says The Wall Street Journal
11:20AM  Why Bristol-Myers Squibb Stock Crashed in April Motley Fool
08:35AM  Mylan Faces EpiPen Shortage as Slowing Sales Trip Up Its Results Bloomberg
06:57AM  The Zacks Analyst Blog Highlights: Berkshire Hathaway, Pfizer, U.S. Bancorp, Tesla and Celgene Zacks
06:32AM  [$$] Hospitals in US sound alarm on impending chemotherapy shortages Financial Times
May-08-18 06:04PM  Mylan says U.S. customers may have trouble getting EpiPens Reuters
02:20PM  Jopwell helps track down minority talent American City Business Journals
01:51PM  The U.S. Is Facing an EpiPen Shortage Bloomberg
10:36AM  Top Analyst Reports for Berkshire Hathaway, Pfizer & U.S. Bancorp Zacks
May-07-18 08:00AM  Wave Life Sciences Highlights Progress on Hepatic Collaboration with Pfizer GlobeNewswire
May-04-18 09:30PM  Drug epidemic ensnares 25-year-old pill for nerve pain Associated Press
04:06PM  Pharma Stock Roundup: Mixed Q1 for MRK, PFE, FDA Nod for Kymriah's 2nd Indication Zacks
12:13PM  Is Trump Willing To Do What It Takes To Reduce High Prescription Drug Prices? Forbes
11:55AM  Q1 Earnings Drag Pharma ETFs Down Zacks
08:02AM  Dow 30 Stock Roundup: AAPL, DWDP, CVX, MRK, MCD, PFE Beat on Earnings Zacks
06:00AM  Eli Lilly Shares Seen Rising 18% as Profits Surge Investopedia
May-03-18 11:51AM  Health-care transparency measures fail en masse at Colorado Legislature American City Business Journals
May-02-18 07:13PM  Edited Transcript of PFE earnings conference call or presentation 1-May-18 2:00pm GMT Thomson Reuters StreetEvents
10:17AM  Company News for May 2, 2018 Zacks
09:36AM  Merck, Pfizer Deliver Checkup on Pharma Sector Bloomberg Video
09:36AM  Merck, Pfizer Deliver Checkup on Pharma Sector Bloomberg
09:15AM  Here's What Pfizer's Saying About 2018 Motley Fool
08:00AM  Why You Should Ditch Growth Stocks, Buy Value Investopedia
12:55AM  Asian shares mostly lower after topsy-turvy day on Wall St Associated Press
May-01-18 11:59PM  [$$] Pfizer Revenue Growth Stalls as Company Mulls OTC Units Future The Wall Street Journal
10:51PM  Dow Industrials Down but Pare Earlier Losses The Wall Street Journal
10:36PM  Pfizer, Inc. (PFE) Q1 2018 Earnings Conference Call Transcript Motley Fool
08:50PM  S&P 500 climbs on trade talk optimism, dollar positive for 2018 Reuters
05:12PM  What Happened in the Stock Market Today Motley Fool
05:07PM  GLOBAL MARKETS-S&P 500 climbs on trade talk optimism, dollar positive for 2018 Reuters
05:03PM  US STOCKS-Wall Street rises on optimism on NAFTA deal and China trade Reuters
04:40PM  S&P, Nasdaq advance on trade optimism Reuters Videos
04:33PM  Seagate, Pfizer and Cummins skid while AbbVie jumps Associated Press
04:11PM  Dow Jones' Merck Slides On Mixed First Quarter As Keytruda Sales Pop Investor's Business Daily
04:08PM  Markets Right Now: Stocks claw back losses, end mostly up Associated Press
04:02PM  Pfizer's Quarterly Sales Brake As Ibrance, Xeljanz Lag Expectations Investor's Business Daily
03:40PM  GLOBAL MARKETS-Dollar turns positive for 2018, U.S. stocks mostly lower Reuters
03:36PM  Stocks recover much of early loss; industrials, energy dip Associated Press
03:34PM  US STOCKS-Wall St pares losses after Lighthizer comments on China Reuters
03:01PM  Pfizer Q1 Earnings: What You Need to Know Motley Fool
02:32PM  With Viagra Now Available Over-The-Counter In The U.K., Will The U.S. Follow Suit? Forbes
02:17PM  Pfizer's 1Q profit up 14 pct., sales just miss expectations Associated Press
01:25PM  Pfizer Inc. Stock Down on Q1 Revenue Miss InvestorPlace
12:14PM  Pfizer: 7 Secrets You Didn't Know (PFE) Investopedia
12:10PM  Pfizer first-quarter results miss estimates as key drug sales fall short Reuters
12:09PM  Pfizer falls to session low CNBC Videos
12:02PM  Dow on track for lowest close in a month as caution grows ahead of Fed meeting MarketWatch
11:57AM  Pfizer Says It Doesn't Need a Major Deal; Investors Unconvinced Bloomberg
11:57AM  Pfizer Pitches Pipeline Over Deals; Investors Aren't Buying Bloomberg
11:54AM  [$$] Pfizer Revenue Growth Stalls as Company Mulls OTC Unit's Future The Wall Street Journal
11:53AM  The Five Biggest Acquisitions in History Investopedia
11:11AM  Health-Care Earnings: Merck, Pfizer Disappoint With Q1 Revenue Barrons.com
10:47AM  ADP Job Data, Q1 Earnings In Focus Zacks
10:20AM  Pfizer's, Merck's revenue disappoint investors Reuters Videos
10:13AM  Pfizer (PFE) Stock Falls on Q1 Sales Miss, Earnings Beat Zacks
09:57AM  Stocks - U.S. Futures Point to Lower Open on Wall Street Investing.com
09:53AM  Merck, Pfizer Report Mixed Results; Market Awaiting Apple, Fed, Jobs Report Forbes
09:41AM  Morning Movers: Under Armour Slumps, Tapestry Tumbles, Pfizer Flops Barrons.com
09:26AM  Stocks to Watch: Apple, Boeing, Pfizer, Hasbro, Tapestry The Wall Street Journal
09:08AM  US STOCKS-Futures down slightly as trade, inflation worries persist Reuters
09:02AM  Pfizer sales miss as breast cancer drug disappoints Reuters
08:45AM  Pfizer sales miss as breast cancer drug disappoints Reuters
08:24AM  Pfizer (PFE) Q1 Earnings Beat, Sales Miss, 2018 View Intact Zacks
08:00AM  Stocks making the biggest moves premarket: MRK, PFE, AAPL, UAA, FB, BA & more CNBC
07:54AM  US STOCKS-Futures little changed as trade, inflation worries persist Reuters
Pfizer Inc. discovers, develops, manufactures, and sells healthcare products worldwide. It operates in two segments, Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). The IH segment focuses on the development and commercialization of medicines and vaccines, and consumer healthcare products in various therapeutic areas, including internal medicine, vaccines, oncology, inflammation and immunology, and rare diseases, as well as consumer healthcare, such as over-the-counter brands comprising dietary supplements, pain management, gastrointestinal, and respiratory and personal care. This segment offers products primarily under the Prevnar 13/Prevenar 13, Xeljanz, Eliquis, Lyrica, Enbrel, Ibrance, Xtandi, Advil, and Centrum brands. The EH segment offers products that would lose or have lost marketing patent protection; branded generic products; generic sterile injectable products; biosimilars; and anti-infectives. It provides products under the Lipitor, Premarin family, Norvasc, Lyrica, Celebrex, Viagra, Inflectra/Remsima, Pristiq, Zyvox, Vfend, Revatio, Inspra, Medrol, Sulperazon, Fragmin, Tygacil, Nivestim, and Retacrit brand names. This segment also engages in the research and development, as well as contract manufacturing activities. Pfizer Inc. has collaboration and/or co-promotion agreements with Bristol-Myers Squibb Company for the development of Eliquis; Astellas Pharma US, Inc. for developing Xtandi; Merck KGaA for the development of Bavencio; and Neofluidics, LLC to develop a microfluidics-based platform. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as centers for disease control and prevention. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
READ IAN CChairman & CEOMay 01Sale36.01132,3124,764,0811,144,703May 03 04:19 PM
JOHNSON RADY AExecutive Vice PresidentMar 13Sale36.5527,323998,66643,178Mar 14 05:19 PM
LANKLER DOUGLAS MExecutive Vice PresidentMar 13Sale36.8950,0001,844,39883,857Mar 14 05:13 PM
Dolsten MikaelPresident R&DMar 09Sale36.5969,6992,550,39451,185Mar 12 05:01 PM
HILL CHARLES HExecutive Vice PresidentMar 06Sale35.7642,3931,515,98557,328Mar 07 04:09 PM
Dolsten MikaelPresident R&DMar 02Sale35.8513,986501,398120,884Mar 05 09:23 AM
HILL CHARLES HExecutive Vice PresidentFeb 28Option Exercise27.37101,8722,788,237207,942Mar 02 03:24 PM
YOUNG JOHN DGroup PresidentFeb 28Option Exercise27.37121,1453,315,739362,707Mar 02 04:10 PM
OLSON LAURIE JExecutive Vice PresidentFeb 28Option Exercise27.3738,5461,055,004132,702Mar 02 04:02 PM
READ IAN CChairman & CEOFeb 28Option Exercise27.37649,78017,784,4791,774,184Mar 02 04:03 PM
SUSMAN SALLYExecutive Vice PresidentFeb 28Option Exercise27.37110,1323,014,313245,362Mar 02 04:03 PM
LUND-JURGENSEN KIRSTENExecutive Vice PresidentFeb 28Option Exercise27.3719,273527,50239,801Mar 02 03:44 PM
JOHNSON RADY AExecutive Vice PresidentFeb 28Option Exercise27.3719,273527,50285,910Mar 02 03:44 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 28Option Exercise27.3746,8061,281,080171,276Mar 02 03:44 PM
Lewis-Hall Freda CExecutive Vice PresidentFeb 28Option Exercise27.37104,6262,863,614384,219Mar 02 03:44 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 28Option Exercise27.37209,2515,727,200655,161Mar 02 03:24 PM
BOURLA ALBERTChief Operating OfficerFeb 28Option Exercise27.3739,9231,092,693184,120Mar 02 03:24 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerFeb 28Option Exercise27.3733,040904,305136,847Mar 02 03:24 PM
Dolsten MikaelPresident R&DFeb 28Option Exercise27.37198,2385,425,774293,352Mar 02 03:24 PM
HILL CHARLES HExecutive Vice PresidentFeb 28Sale36.8326,779986,292181,163Mar 02 03:24 PM
SUSMAN SALLYExecutive Vice PresidentFeb 27Sale37.0333,3681,235,591135,230Feb 28 06:14 PM
Dolsten MikaelPresident R&DFeb 27Sale37.0464,5872,392,31395,114Feb 28 06:04 PM
CORNWELL W DONDirectorFeb 27Sale37.0530011,1150Feb 28 01:29 PM
LUND-JURGENSEN KIRSTENExecutive Vice PresidentFeb 26Sale37.199,510353,67717,770Feb 27 07:38 PM
CORNWELL W DONDirectorFeb 26Sale36.741,45853,5640Feb 28 01:29 PM
YOUNG JOHN DGroup PresidentFeb 24Option Exercise18.9043,520822,528223,733Feb 27 08:59 PM
READ IAN CChairman & CEOFeb 24Option Exercise19.83903,55917,917,2651,560,007Feb 27 08:58 PM
OLSON LAURIE JExecutive Vice PresidentFeb 24Option Exercise18.9015,716297,03290,222Feb 27 07:53 PM
SUSMAN SALLYExecutive Vice PresidentFeb 24Option Exercise18.9091,8761,736,456206,972Feb 27 07:51 PM
JOHNSON RADY AExecutive Vice PresidentFeb 24Option Exercise18.9015,885300,22762,848Feb 27 07:43 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 24Option Exercise18.9028,288534,643112,081Feb 27 07:43 PM
Lewis-Hall Freda CExecutive Vice PresidentFeb 24Option Exercise18.9091,8761,736,456313,499Feb 27 07:43 PM
LUND-JURGENSEN KIRSTENExecutive Vice PresidentFeb 24Option Exercise18.9015,957301,58736,959Feb 27 07:38 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentFeb 24Option Exercise18.9039,555747,590143,152Feb 27 07:38 PM
HILL CHARLES HExecutive Vice PresidentFeb 24Option Exercise18.9065,2801,233,792122,609Feb 27 07:38 PM
Dolsten MikaelPresident R&DFeb 24Option Exercise18.90174,0813,290,131225,265Feb 27 07:32 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerFeb 24Option Exercise18.9028,288534,643116,769Feb 27 07:30 PM
BOURLA ALBERTChief Operating OfficerFeb 24Option Exercise18.9025,387479,814158,170Feb 27 07:30 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 24Option Exercise18.90174,0813,290,131511,470Feb 27 07:30 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentDec 15Sale37.006,750249,750103,458Dec 18 06:17 PM
JOHNSON RADY AExecutive Vice PresidentDec 15Sale37.078,000296,56046,963Dec 18 06:17 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentNov 01Sale34.947,350256,809110,082Nov 02 07:03 PM
PFIZER INC10% OwnerOct 10Buy17.0040,000680,0001,427,639Oct 10 04:22 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentOct 02Sale35.657,350262,028117,432Nov 02 07:03 PM
SUSMAN SALLYExecutive Vice PresidentSep 12Sale35.0038,2301,338,050115,096Sep 14 09:13 AM
MACKENZIE ALEXANDER RExecutive Vice PresidentSep 01Sale34.007,350249,900124,774Sep 05 06:15 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentAug 31Sale34.007,350249,900132,124Sep 01 06:37 PM
DAMELIO FRANK AExecutive Vice PresidentAug 31Sale34.0094,4093,209,906337,389Sep 01 06:37 PM
READ IAN CChairman & CEOAug 31Sale34.00141,1934,800,56280,762Sep 01 06:37 PM
READ IAN CChairman & CEOAug 31Sale34.0055,9751,903,150580,318Sep 01 06:37 PM
OLSON LAURIE JExecutive Vice PresidentAug 21Sale32.708,064263,69374,506Aug 23 03:51 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentAug 07Sale33.5015,000502,560139,474Aug 09 05:00 PM
READ IAN CChairman & CEOAug 04Sale34.0068,8342,340,356221,955Aug 08 05:02 PM
READ IAN CChairman & CEOAug 04Sale34.0028,116955,944636,293Aug 08 05:02 PM